Gene Expression of MicroRNA-205, FGF2 and CARMA3 in Colorectal Cancer in Iraqi Patients

Key Points

• The research aims to evaluate the expression of miR-205, FGF2, and CARMA3 as biomarkers for colorectal cancer.
• Analysis of gene expression levels of miR-205, FGF2, and CARMA3 in colorectal cancer tissues.
• Comparison of these biomarker levels in colorectal cancer versus normal tissues.
• Evaluation of the potential of these markers in multi-marker diagnostic panels.
• miR-205, FGF2, and CARMA3 show distinct expression patterns in colorectal cancer tissues.
• These biomarkers indicate potential for improved diagnostic accuracy.
• Clinical utility needs further testing in larger patient cohorts.